taken together the results show that mecamylamine treatment ( 2 x 1 mg/kg ) differentially counteract nicotine induced changes of amine levels and turnover in peri- ( anterior part ) and paraventricular na nerve terminal systems indicating that the cholinergic nicotine-like receptors located in peri- ( anterior part ) and paraventricular areas may be more susceptible to the blocking activity of mecamylamine than those located in the median eminence area .
C0027763
nerve
C0233660
blocking